Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 283,300 shares, an increase of 113.3% from the December 15th total of 132,800 shares. Based on an average daily volume of 128,139,400 shares, the short-interest ratio is presently 0.0 days.

Therapeutic Solutions International Stock Performance

OTCMKTS:TSOI traded down $0.00 on Tuesday, reaching $0.00. 253,172,890 shares of the stock traded hands, compared to its average volume of 71,947,977. Therapeutic Solutions International has a 12 month low of $0.00 and a 12 month high of $0.00.

About Therapeutic Solutions International

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.